Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors
John A. Grout, Philémon Sirven, Andrew M. Leader, et al.
Cancer Discovery (2022) Vol. 12, Iss. 11, pp. 2606-2625
Open Access | Times Cited: 156

Showing 1-25 of 156 citing articles:

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1233
The cancer-immunity cycle: Indication, genotype, and immunotype
Ira Mellman, Daniel S. Chen, Thomas Powles, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2188-2205
Open Access | Times Cited: 273
Fibroblasts in cancer: Unity in heterogeneity
Yash Chhabra, Ashani T. Weeraratna
Cell (2023) Vol. 186, Iss. 8, pp. 1580-1609
Closed Access | Times Cited: 156
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 117
Cancer-associated fibroblast classification in single-cell and spatial proteomics data
Lena Cords, Sandra Tietscher, Tobias Anzeneder, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 106
B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity
Céline M. Laumont, Brad H. Nelson
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 466-489
Open Access | Times Cited: 71
Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors
Zebin Xiao, Leslie Todd, Li Huang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 70
Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer
Lena Cords, Stefanie Engler, Martina Haberecker, et al.
Cancer Cell (2024) Vol. 42, Iss. 3, pp. 396-412.e5
Open Access | Times Cited: 62
The advent of immune stimulating CAFs in cancer
Maria Tsoumakidou
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 258-269
Closed Access | Times Cited: 61
Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers
Kellen Wright, Thuc Ly, Matthew Kriet, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1899-1899
Open Access | Times Cited: 60
Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 3888-3888
Open Access | Times Cited: 59
The dynamic role of platelets in cancer progression and their therapeutic implications
Suping Li, Zefang Lu, Suying Wu, et al.
Nature reviews. Cancer (2023) Vol. 24, Iss. 1, pp. 72-87
Closed Access | Times Cited: 51
Friend or foe? The elusive role of hepatic stellate cells in liver cancer
Bruno Cogliati, Chittampalli Yashaswini, Shuang Wang, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 647-661
Open Access | Times Cited: 44
From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts
Ludovica Arpinati, Ruth Scherz‐Shouval
Trends in cancer (2023) Vol. 9, Iss. 5, pp. 421-443
Closed Access | Times Cited: 43
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer
Katey S.S. Enfield, Emma Colliver, Claudia Lee, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 1018-1047
Open Access | Times Cited: 22
T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution
Wenhui Yang, Shimao Liu, Mengyun Mao, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 18
Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas
Marina T. Broz, Emily Y. Ko, Kristin Ishaya, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
Minae An, Arnav Mehta, Byung‐Hoon Min, et al.
Cancer Discovery (2024) Vol. 14, Iss. 5, pp. 766-785
Open Access | Times Cited: 13
Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer
Hugo Croizer, Rana Mhaidly, Yann Kieffer, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Cancer-associated fibroblasts expressing fibroblast activation protein and podoplanin in non-small cell lung cancer predict poor clinical outcome
Layla Mathieson, Lilian Koppensteiner, David A. Dorward, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 11, pp. 1758-1769
Open Access | Times Cited: 12
Spatiotemporal omics for biology and medicine
Longqi Liu, Ao Chen, Yuxiang Li, et al.
Cell (2024) Vol. 187, Iss. 17, pp. 4488-4519
Closed Access | Times Cited: 12
Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation
Yang Gao, Jianan Li, Wenfeng Cheng, et al.
Cancer Cell (2024)
Open Access | Times Cited: 12
Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma
Amelia L. Parker, Elise D. Bowman, Adriana Zingone, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 36
Sonodynamic-immunomodulatory nanostimulators activate pyroptosis and remodel tumor microenvironment for enhanced tumor immunotherapy
Zhuang Chen, Weijing Liu, Zuo Yang, et al.
Theranostics (2023) Vol. 13, Iss. 5, pp. 1571-1583
Open Access | Times Cited: 34
Dissecting the role of cancer‐associated fibroblast‐derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single‐cell transcriptomic study
Shaoquan Zheng, Jie‐Ying Liang, Yuhui Tang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 2
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top